Skip to main content Accessibility help
×
Hostname: page-component-75d7c8f48-bjh2l Total loading time: 0 Render date: 2026-03-13T16:04:03.536Z Has data issue: false hasContentIssue false

Section VII - Other uncommon causes of iatrogenic stroke

Published online by Cambridge University Press:  20 October 2016

Edited by
Alexander Tsiskaridze ,
Arne Lindgren  and
Adnan I. Qureshi
Alexander Tsiskaridze
Affiliation:
Sarajishvili Institute of Neurology, Tblisi State University, Georgia
Arne Lindgren
Affiliation:
Department of Neurology, University Hospital Lund, Sweden
Adnan I. Qureshi
Affiliation:
Department of Neurology, University of Minnesota
Get access

Information

Type
Chapter
Information
Treatment-Related Stroke
Including Iatrogenic and In-Hospital Strokes
 , pp. 203 - 240
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

References

George, M G, Tong, X, Kuklina, E V, Labarthe, D R. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995–2008. Ann Neurol. 2011; 70:713–21.CrossRefGoogle Scholar
Dias, M, Sekhar, L. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990; 27:855–65.CrossRefGoogle ScholarPubMed
James, A, Bushnell, C D, Jaminson, M G, Myers, E R. Incidence and risk factors for stroke in pregnancy and puerperium. Obstet Gynecol. 2005; 106:509–16.CrossRefGoogle Scholar
Say, L, Souza, J P, Pattinson, R C; WHO working group on Maternal Mortality and Morbidity classifications. Maternal near miss: Towards a standard tool for monitoring quality of maternal health care. Best Pract Res Clin Obstet Gynaecol. 2009; 23:287–96.CrossRefGoogle ScholarPubMed
Kuklina, E V, Tong, X, Bansil, P, George, M G, Callaghan, W M. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: Reasons for concern? Stroke. 2011; 42:2564–70.CrossRefGoogle ScholarPubMed
Sharshar, T, Lamy, C, Mas, J L, The Stroke in Pregnancy Group. Incidence and causes of stroke associated with pregnancy and puerperium: a study in public hospitals of Ile de France. Stroke. 1995; 26:930–6.CrossRefGoogle ScholarPubMed
Liang, C C, Chang, S D, Lai, S L, et al. Stroke complicating pregnancy and the puerperium. Eur J Neurol. 2006; 13:1256–60.CrossRefGoogle ScholarPubMed
Wiebers, D O, Whisnant, J P. The incidence of stroke among pregnant women in Rochester, Minn, 1955 through 1979. JAMA. 1985; 254:3055–7.CrossRefGoogle ScholarPubMed
Awada, A, al Rajeh, S, Duarte, R, Russell, N. Stroke and pregnancy. Int J Gynaecol Obstet. 1995; 48:157–61.CrossRefGoogle ScholarPubMed
Kittner, S J, Stern, B J, Feeser, B R, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996; 335:768–74.CrossRefGoogle ScholarPubMed
Witlin, A G, Friedman, S A, Egerman, R S, Frangieh, A Y, Sibai, B M. Cerebrovascular disorders complicating pregnancy: beyond eclampsia. Am J Obstet Gynecol. 1997; 176:1139–45.CrossRefGoogle ScholarPubMed
Jaigobin, C, Silver, F L. Stroke and pregnancy. Stroke. 2000; 31:2948–51.CrossRefGoogle ScholarPubMed
Skidmore, F M, Williams, L S, Fradkin, K D, Alonso, R J, Biller, J. Presentation, etiology and outcome of stroke in pregnancy and puerperium. J Stroke Cerebrovasc Dis. 2001; 10:1–10.CrossRefGoogle ScholarPubMed
Jeng, J S, Tang, S C, Yip, P K. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004; 18:290–5.CrossRefGoogle ScholarPubMed
Ros, H S, Lichtestein, P, Bellocco, R, Petersson, R, Cnattingius, S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology. 2001; 12:456–60.Google Scholar
Hunter, S, Robson, S C. Adaptation of the maternal heart in pregnancy. Brit Heart J. 1992; 68:540–3.CrossRefGoogle ScholarPubMed
Bremme, K A. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003; 16:153–68.CrossRefGoogle ScholarPubMed
ACOG Committee on Obstetric Practice. ACOG Committee Opinion Number 299, September 2004. Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. 2004; 104:647–51.Google Scholar
Kanal, E, Borgstede, J P, Barkovich, A J, et al. American College of Radiology. American College of Radiology White Paper on MR Safety. Am J Roentgenol. 2002; 178:1335–47.CrossRefGoogle ScholarPubMed
Stoddard, M F, Longaker, R A, Vuocolo, L M, Dawkins, P R. Trans-esophageal echocardiography in the pregnant patient. Am Heart J. 1992; 124:785–7.CrossRefGoogle Scholar
Lanska, D J, Kryscio, R J. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke. 2000; 31:1274–82.CrossRefGoogle ScholarPubMed
Ros, H S, Lichtenstein, P, Bellocco, R, Petersson, G, Cnattingius, S. Pulmonary embolism and stroke in relation to pregnancy: How can high-risk women be identified? Am J Obstet Gynecol. 2002; 186:198–203.CrossRefGoogle ScholarPubMed
Clark, S L, Hankins, G D, Dudley, D A, Dildy, G A, Porter, T F. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol. 1995; 172:1158–69.CrossRefGoogle ScholarPubMed
Sibai, B, Dekker, G, Kupferminc, M. Pre-eclampsia. Lancet. 2005; 365:785–99.CrossRefGoogle ScholarPubMed
Moodley, J, Kalane, G. A review of the management of eclampsia: practical issues. Hypertens Pregnancy. 2006; 25:47–62.CrossRefGoogle ScholarPubMed
Roberts, J M, Cooper, D W. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001; 357:53–6.CrossRefGoogle ScholarPubMed
Elkayam, U, Akhter, M W, Singh, H, et al. Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation. 2005; 111:2050–5.CrossRefGoogle Scholar
Abboud, J, Murad, Y, Chen-Scarabelli, C, Saravolatz, L, Scarabelli, T. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol. 2007; 118:295–303.CrossRefGoogle ScholarPubMed
Pearson, G D, Veille, J C, Rahimtoola, S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000; 283:1183–8.CrossRefGoogle ScholarPubMed
Mas, J L, Lamy, C. Stroke in pregnancy and the puerperium. J Neurol. 1998; 245:305–13.CrossRefGoogle ScholarPubMed
Fugate, J E, Ameriso, S F, Ortiz, G, et al. Variable presentations of postpartum angiopathy. Stroke. 2012; 43:670–6.CrossRefGoogle ScholarPubMed
Huang, C Y, Chen, C A, Hsieh, C Y, Cheng, W F. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: A case report and literature review. Int J Gynecol Cancer. 2007; 17:1166–71.CrossRefGoogle ScholarPubMed
Lanska, D J, Kryscio, R J. Peripartum stroke and intracranial venous thrombosis in the National Hospital Discharge Survey. Obstet Gynecol. 1997; 89:413–18.CrossRefGoogle ScholarPubMed
Lanska, D J, Kryscio, R J. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology. 1998; 51:1622–8.CrossRefGoogle ScholarPubMed
Cantu, C, Barinagarrementaria, F. Cerebral venous thrombosis associated with pregnancy and the puerperium: a review of 67 cases. Stroke. 1993; 24:1880–4.CrossRefGoogle ScholarPubMed
Furie, K L, Kasner, S E, Adams, R J, et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:227–76.Google ScholarPubMed
Bates, S, Greer, I, Pabinger, I, Sofaer, S, Hirsch, J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Chest. 2008; 133:844S–886S.CrossRefGoogle ScholarPubMed
Kozer, E, Nikfar, S, Costei, A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol. 2002; 187:1623–30.CrossRefGoogle ScholarPubMed
Coomarasamy, A, Honest, H, Papaioannou, S, Gee, H, Khan, K S. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol. 2003; 101:1319–32.Google ScholarPubMed
Greer, I A, Nelson-Piercy, C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005; 106:401–7.CrossRefGoogle ScholarPubMed
Leonhardt, G, Gaul, C, Nietsch, H H, Buerke, M, Schleussner, E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006; 21:271–6.CrossRefGoogle ScholarPubMed
Dapprich, M, Boessenecker, W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis. 2002; 13:290.CrossRefGoogle Scholar
Elford, K, Leader, A, Wee, R, Stys, P K. Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology. 2002; 59:1270–2.CrossRefGoogle ScholarPubMed
Johnson, D M, Kramer, D C, Cohen, E, et al. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke. 2005; 36:e53–e55.CrossRefGoogle ScholarPubMed
Wiese, K M, Talkad, A, Mathews, M, Wang, D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke. 2006; 37:2168–9.CrossRefGoogle Scholar
Murugappan, A, Coplin, W M, Al-Sadat, A N, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology. 2006; 66:768–70.CrossRefGoogle ScholarPubMed
Li, Y, Margraf, J, Kluck, B, Jenny, D, Castaldo, J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: A case report and literature review. Neurologist. 2012; 18:44–8.CrossRefGoogle ScholarPubMed
Mantoan Ritter, L, Schüler, A, Gangopadhyay, R, et al. Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol. 2014; 261:632–4.CrossRefGoogle ScholarPubMed
Méndez, J C, Masjuán, J, García, N, de Leciñana, M. Successful intra-arterial thrombolysis for acute ischemic stroke in the immediate postpartum period: Case report. Cardiovasc Intervent Radiol. 2008; 31:193–5.CrossRefGoogle ScholarPubMed
Rønning, O M, Dahl, A, Bakke, S J, Hussain, A I, Deilkås, E. Stroke in the puerperium treated with intra-arterial rt-PA. J Neurol Neurosurg Psychiatry. 2010; 81:585–6.CrossRefGoogle ScholarPubMed
Barrett, J M, Van Hooydonk, J E, Boehm, F H. Pregnancy-related rupture of arterial aneurysms. Obstet Gynecol Surv. 1982; 37:557–66.CrossRefGoogle ScholarPubMed
Marshman, L A, Aspoas, A R, Rai, M S, Chawda, S J. The implications of ISAT and ISUIA for the management of cerebral aneurysms during pregnancy. Neurosurg Rev. 2007; 30:177–80.CrossRefGoogle ScholarPubMed
Meyers, P M, Halbach, V V, Malek, A M, et al. Endovascular treatment of cerebral artery aneurysms during pregnancy: Report of three cases. Am J Neuroradiol. 2000; 21:1306–11.Google ScholarPubMed
Piotin, M, Filho, C B A, Kothimbakam, R, Moret, J. Endovascular treatment of acutely ruptured intracranial aneurysm in pregnancy. Am J Obstet Gynecol. 2001; 185:1261–2.CrossRefGoogle Scholar
Marshman, L A G, Aspoas, A R, Rai, M S. Endovascular treatment of ruptured intracranial aneurysms during pregnancy: Letter. Arch Gynecol Obstet. 2005; 272:93.CrossRefGoogle Scholar
Bateman, B, Schumacher, H, Bushnell, C D, et al. Intracerebral hemorrhage in pregnancy. Frequency, risk factors, and outcome. Neurology. 2006; 67:424–9.CrossRefGoogle ScholarPubMed
Sawin, P. Spontaneous subarachnoid hemorrhage in pregnancy and the puerperium. In Loftus, C, ed. Neurological Aspects of Pregnancy. Park Ridge, IL: American Association of Neurological Surgeons; 1996: 85–99.Google Scholar
Roman, H, Descargues, G, Lopes, M, et al. Subarachnoid hemorrhage due to cerebral aneurysmal rupture during pregnancy. Acta Obstet Gynecol Scand. 2004; 83:330–4.CrossRefGoogle ScholarPubMed
Wright, V C, Schieve, L A, Reynolds, M A, Jeng, G. Assisted reproductive technology surveillance in United States, 2002. MMWR. 2005; 54:1–24.Google ScholarPubMed
Whelan, J G, Vlahos, N F. The ovarian hyperstimulation syndrome. Fertil Steril. 2000; 73:893–6.CrossRefGoogle ScholarPubMed
Chan, W S, Dixon, M E. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008; 121:713–26.CrossRefGoogle Scholar
Kodama, H, Fukuda, J, Karube, H, et al. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril. 1996; 66:417–24.CrossRefGoogle ScholarPubMed

References

Watson, T, Shantsila, E, Lip, G Y. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009; 373(9658):155–66.CrossRefGoogle ScholarPubMed
Manning, W J, et al. Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994; 23(7):1535–40.CrossRefGoogle Scholar
O’Neill, P G, et al. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J. 1990; 120(2):353–9.Google ScholarPubMed
Shapiro, E P, et al. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol. 1988; 62(17):1202–7.CrossRefGoogle ScholarPubMed
Ikram, H, Nixon, PG, Arcan, T. Left atrial function after electrical conversion to sinus rhythm. Br Heart J. 1968; 30(1):80–3.CrossRefGoogle ScholarPubMed
Manning, W J, et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 1989; 13(3):617–23.CrossRefGoogle ScholarPubMed
Grimm, R A, et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993; 22(5):1359–66.CrossRefGoogle ScholarPubMed
Black, I W, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation. 1994; 89(6):2509–13.CrossRefGoogle Scholar
Black, I W, et al. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J. 1993; 126(2):375–81.CrossRefGoogle ScholarPubMed
Missault, L, et al. Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography. Eur Heart J. 1994; 15(9):1279–80.Google ScholarPubMed
Bjerkelund, C J, Orning, O M. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol. 1969; 23(2):208–16.CrossRefGoogle Scholar
Lown, B. Electrical reversion of cardiac arrhythmias. Br Heart J. 1967; 29(4):469–89.CrossRefGoogle ScholarPubMed
Oram, S, Davies, J P. Further experience of electrical conversion of atrial fibrillation to sinus rhythm: Analysis of 100 patients. Lancet. 1964; 1(7346):1294–8.Google ScholarPubMed
Resnekov, L, McDonald, L. Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion. Br Heart J. 1967; 29(6):926–36.CrossRefGoogle ScholarPubMed
McCarthy, C, Varghese, P J, Barritt, D W. Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up. Br Heart J. 1969; 31(4):496–500.CrossRefGoogle ScholarPubMed
Berger, M, Schweitzer, P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis. Am J Cardiol. 1998; 82(12):1545–7.CrossRefGoogle ScholarPubMed
Gallagher, M M, et al. Embolic complications of direct current cardioversion of atrial arrhythmias: Association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol. 2002; 40(5):926–33.CrossRefGoogle ScholarPubMed
Arnold, A Z, et al. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992; 19(4):851–5.CrossRefGoogle ScholarPubMed
Collins, L J, et al. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation. 1995; 92(2):160–3.CrossRefGoogle ScholarPubMed
Israel, C W, et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004; 43(1):47–52.CrossRefGoogle Scholar
Camm, A J, et al. focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012; 33(21):2719–47.Google ScholarPubMed
Camm, A J, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31(19):2369–429.Google ScholarPubMed
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Connolly, S J, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139–51.CrossRefGoogle ScholarPubMed
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Nagarakanti, R, et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation. 2011; 123(2):131–6.CrossRefGoogle ScholarPubMed
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed on September 27, 2015].Google Scholar
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Granger, C B, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365:981–92.CrossRefGoogle ScholarPubMed
Flaker, G, et al. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: Insights from the ARISTOTLE trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation). Journal of the American College of Cardiology. 2014; 63:1082–7.CrossRefGoogle ScholarPubMed
Patel, M R, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011; 365:883–91.CrossRefGoogle ScholarPubMed
Cappato, R, et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. European Heart Journal. 2014; 35:3346–55.CrossRefGoogle ScholarPubMed
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar
Weigner, M J, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med. 1997; 126:615–20.CrossRefGoogle ScholarPubMed
Stoddard, M F, et al. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J. 1995; 129(6):1204–15.CrossRefGoogle ScholarPubMed
Stoddard, M F, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol. 1995; 25(2):452–9.CrossRefGoogle ScholarPubMed
Klein, A L, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001; 344(19):1411–20.CrossRefGoogle ScholarPubMed
Weigner, M J, et al. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: Short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med. 2001; 110(9):694–702.CrossRefGoogle ScholarPubMed
Camm, A J, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12(10):1360–420.Google ScholarPubMed
www.uptodate.com/contents/warfarin-drug-information?source=see_link. [Accessed September 27, 2015].Google Scholar

References

Tisdale, J E, Miller, D A. American Society of Health-System Pharmacists. Drug-induced Diseases: Prevention, Detection, and Management. Bethesda, MD: American Society of Health-System Pharmacists; 2005.Google Scholar
Flaherty, M L. Anticoagulant-associated intracerebral hemorrhage. Seminars in Neurology. 2010; 30:565–72.CrossRefGoogle ScholarPubMed
Cantu, C, Arauz, A, Murillo-Bonilla, L M, Lopez, M, Barinagarrementeria, F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003; 34:1667–72.CrossRefGoogle ScholarPubMed
Jain, K K. Drug-induced Neurological Disorders. Cambridge, MA: Hogrefe Pub; 2012.Google Scholar
Plu-Bureau, G, Hugon-Rodin, J, Maitrot-Mantelet, L, Canonico, M. Hormonal contraceptives and arterial disease: An epidemiological update. Best Practice & Research. Clinical Endocrinology & Metabolism. 2013; 27:35–45.CrossRefGoogle ScholarPubMed
Plu-Bureau, G, Maitrot-Mantelet, L, Hugon-Rodin, J, Canonico, M. Hormonal contraceptives and venous thromboembolism: An epidemiological update. Best Practice & Research. Clinical Endocrinology & Metabolism. 2013; 27:25–34.CrossRefGoogle ScholarPubMed
Godsland, I F, Winkler, U, Lidegaard, O, Crook, D. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. Drugs. 2000; 60:721–869.CrossRefGoogle ScholarPubMed
Meade, T W, Greenberg, G, Thompson, S G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. British Medical Journal. 1980; 280:1157–61.CrossRefGoogle Scholar
Lidegaard, O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: The influence of diabetes, hypertension, migraine and previous thrombotic disease. British Journal of Obstetrics and Gynaecology. 1995; 102:153–9.Google ScholarPubMed
Lidegaard, O, Kreiner, S. Contraceptives and cerebral thrombosis: A five-year national case-control study. Contraception. 2002; 65:197–205.CrossRefGoogle ScholarPubMed
Chan, W S, Ray, J, Wai, E K, et al. Risk of stroke in women exposed to low-dose oral contraceptives: A critical evaluation of the evidence. Archives of Internal Medicine. 2004; 164:741–7.CrossRefGoogle ScholarPubMed
Schurks, M, Rist, P M, Bigal, M E, et al. Migraine and cardiovascular disease: Systematic review and meta-analysis. British Medical Journal. 2009; 339:b3914.CrossRefGoogle ScholarPubMed
Saposnik, G, Barinagarrementeria, F, Brown, R D Jr., et al. Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:1158–92.CrossRefGoogle ScholarPubMed
Saadatnia, M, Naghavi, N, Fatehi, F, Zare, M, Tajmirriahi, M. Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis. Journal of Research in Medical Sciences. 2012; 17:344–7.Google ScholarPubMed
Ashjazadeh, N, Borhani Haghighi, A, Poursadeghfard, M, Azin, H. Cerebral venous-sinus thrombosis: A case series analysis. Iranian Journal of Medical Sciences. 2011; 36:178–82.Google ScholarPubMed
Martinelli, I, Sacchi, E, Landi, G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. New England Journal of Medicine. 1998; 338:1793–7.CrossRefGoogle ScholarPubMed
de Bruijn, S F, Stam, J, Koopman, M M, Vandenbroucke, J P. The Cerebral Venous Sinus Thrombosis Study Group. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. British Medical Journal. 1998; 316:589–92.CrossRefGoogle ScholarPubMed
Dentali, F, Crowther, M, Ageno, W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: A meta-analysis. Blood. 2006; 107:2766–73.CrossRefGoogle ScholarPubMed
Dunne, C, Malyuk, D, Firoz, T. Cerebral venous sinus thrombosis in a woman using the etonogestrel-ethinyl estradiol vaginal contraceptive ring: A case report. Journal of Obstetrics and Gynaecology Canada. 2010; 32:270–3.CrossRefGoogle Scholar
Shetty, K D, Vogt, W B, Bhattacharya, J. Hormone replacement therapy and cardiovascular health in the United States. Medical Care. 2009; 47:600–6.CrossRefGoogle ScholarPubMed
Rossouw, J E, Anderson, G L, Prentice, R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. Journal of the American Medical Association. 2002; 288:321–33.Google ScholarPubMed
Wassertheil-Smoller, S, Hendrix, S L, Limacher, M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The women’s health initiative: A randomized trial. Journal of the American Medical Association. 2003; 289:2673–84.Google ScholarPubMed
Ruige, J B, Mahmoud, A M, De Bacquer, D, Kaufman, J M. Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis. Heart. 2011; 97:870–5.CrossRefGoogle ScholarPubMed
Yeap, B B, Hyde, Z, Almeida, O P, et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. Journal of Clinical Endocrinology and Metabolism. 2009; 94:2353–9.Google ScholarPubMed
Ferenchick, G, Schwartz, D, Ball, M, Schwartz, K. Androgenic-anabolic steroid abuse and platelet aggregation: A pilot study in weight lifters. American Journal of the Medical Sciences. 1992; 303:78–82.CrossRefGoogle ScholarPubMed
Stergiopoulos, K, Brennan, J J, Mathews, R, Setaro, J F, Kort, S. Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature. Vascular Health and Risk Management. 2008; 4:1475–80.CrossRefGoogle ScholarPubMed
Warkentin, T E, Greinacher, A, Koster, A, Lincoff, A M. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133:340S–380S.CrossRefGoogle ScholarPubMed
Linkins, L A, Dans, A L, Moores, L K, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:e495S–530S.CrossRefGoogle ScholarPubMed
Visentin, G P, Ford, S E, Scott, J P, Aster, R H. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. Journal of Clinical Investigation. 1994; 93:81–8.CrossRefGoogle ScholarPubMed
Newman, P M, Chong, B H. Heparin-induced thrombocytopenia: New evidence for the dynamic binding of purified anti-pf4-heparin antibodies to platelets and the resultant platelet activation. Blood. 2000; 96:182–7.CrossRefGoogle ScholarPubMed
Giossi, A, Del Zotto, E, Volonghi, I, et al. Thromboembolic complications of heparin-induced thrombocytopenia. Blood Coagulation & Fibrinolysis. 2012; 23:559–62.CrossRefGoogle ScholarPubMed
LaMonte, M P, Brown, P M, Hursting, M J. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy. Critical Care Medicine. 2004; 32:976–80.CrossRefGoogle ScholarPubMed
Li, S H, Chen, W H, Tang, Y, et al. Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients. Clinical Neurology and Neurosurgery. 2006; 108:150–6.CrossRefGoogle ScholarPubMed
Czaykowski, P M, Moore, M J, Tannock, I F. High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. Journal of Urology. 1998; 160:2021–4.CrossRefGoogle ScholarPubMed
Wall, J G, Weiss, R B, Norton, L, et al. Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A cancer and leukemia group B study. American Journal of Medicine. 1989; 87:501–4.CrossRefGoogle ScholarPubMed
Bachaud, J M, David, J M, Shubinski, R E, et al. Predictive factors of a complete response to and adverse effects of a cddp-5fu combination as primary therapy for head and neck squamous carcinomas. Journal of Laryngology and Otology. 1993; 107:924–30.CrossRefGoogle ScholarPubMed
Skali, H, Parving, H H, Parfrey, P S, et al. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darbepoetin alfa: The trial to reduce cardiovascular events with aranesp therapy (treat) experience. Circulation. 2011; 124:2903–8.CrossRefGoogle ScholarPubMed
Pfeffer, M A, Burdmann, E A, Chen, C Y, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New England Journal of Medicine. 2009; 361:2019–32.CrossRefGoogle ScholarPubMed
FDA Drug Safety Communication. Erythropoiesis-stimulating agents (ESAS): Procrit, epogen and aranesp. 2010.Google Scholar
FDA Drug Safety Communication. Modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAS) in chronic kidney disease. 2011.Google Scholar
Ehrenreich, H, Weissenborn, K, Prange, H, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009; 40:e647–656.CrossRefGoogle ScholarPubMed
Fergusson, D A, Hebert, P C, Mazer, C D, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New England Journal of Medicine. 2008; 358:2319–31.CrossRefGoogle ScholarPubMed
Mangano, D T, Tudor, I C, Dietzel, C. The risk associated with aprotinin in cardiac surgery. New England Journal of Medicine. 2006; 354:353–65.CrossRefGoogle ScholarPubMed
Roberts, I, Perel, P, Prieto-Merino, D, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: Prespecified analysis of data from randomised controlled trial. British Medical Journal. 2012; 345:e5839.CrossRefGoogle ScholarPubMed
Roos, Y B, Rinkel, G J, Vermeulen, M, Algra, A, van Gijn, J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews. 2003: CD001245.CrossRefGoogle Scholar
Idbaih, A, Crassard, I, Vahedi, K, Guichard, J P, Woimant, F. Thrombotic cocktail in stroke. Neurology. 2005; 64:334.CrossRefGoogle ScholarPubMed
Brown, J E, Olujohungbe, A, Chang, J, et al. All-trans retinoic acid (ATRA) and tranexamic acid: A potentially fatal combination in acute promyelocytic leukaemia. British Journal of Haematology. 2000; 110:1010–12.CrossRefGoogle ScholarPubMed
Caress, J B, Cartwright, M S, Donofrio, P D, Peacock, J E Jr. The clinical features of 16 cases of stroke associated with administration of IVIG. Neurology. 2003; 60:1822–4.CrossRefGoogle ScholarPubMed
Katz, U, Shoenfeld, Y. Review: Intravenous immunoglobulin therapy and thromboembolic complications. Lupus. 2005; 14:802–8.CrossRefGoogle ScholarPubMed
Orbach, H, Katz, U, Sherer, Y, Shoenfeld, Y. Intravenous immunoglobulin: Adverse effects and safe administration. Clinical Reviews in Allergy & Immunology. 2005; 29:173–84.CrossRefGoogle ScholarPubMed
Caress, J B, Hobson-Webb, L, Passmore, L V, Finkbiner, A P, Cartwright, M S. Case-control study of thromboembolic events associated with IV immunoglobulin. Journal of Neurology. 2009; 256:339–42.CrossRefGoogle ScholarPubMed
Haag, M D, Bos, M J, Hofman, A, et al. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke. Archives of Internal Medicine. 2008; 168:1219–24.CrossRefGoogle ScholarPubMed
Roumie, C L, Mitchel, E F Jr., Kaltenbach, L, et al. Nonaspirin NSAIDS, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke. 2008; 39:2037–45.CrossRefGoogle ScholarPubMed
Andersohn, F, Schade, R, Suissa, S, Garbe, E. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: A nested case-control study. Stroke. 2006; 37:1725–30.CrossRefGoogle ScholarPubMed
Fosbol, E L, Olsen, A M, Olesen, J B, et al. Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safety. International Journal of Stroke. 2012; 9:943–5.Google ScholarPubMed
Chang, C H, Shau, W Y, Kuo, C W, Chen, S T, Lai, M S. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: A nationwide case-crossover study. Stroke. 2010; 41:1884–90.CrossRefGoogle ScholarPubMed
Bennett, J S, Daugherty, A, Herrington, D, et al. The use of nonsteroidal anti-inflammatory drugs (NSAIDS): A science advisory from the American Heart Association. Circulation. 2005; 111:1713–16.CrossRefGoogle ScholarPubMed
Antman, E M, Bennett, J S, Daugherty, A, et al. Use of nonsteroidal antiinflammatory drugs: An update for clinicians: A scientific statement from the American Heart Association. Circulation. 2007; 115:1634–42.CrossRefGoogle ScholarPubMed
Sklar, P, Masur, H. HIV infection and cardiovascular disease: Is there really a link? New England Journal of Medicine. 2003; 349:2065–7.CrossRefGoogle ScholarPubMed
Engstrom, J W, Lowenstein, D H, Bredesen, D E. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. American Journal of Medicine. 1989; 86:528–32.CrossRefGoogle ScholarPubMed
Qureshi, A I, Janssen, R S, Karon, J M, et al. Human immunodeficiency virus infection and stroke in young patients. Archives of Neurology. 1997; 54:1150–3.CrossRefGoogle ScholarPubMed
Mochan, A, Modi, M, Modi, G. Protein S deficiency in HIV associated ischaemic stroke: An epiphenomenon of HIV infection. Journal of Neurology, Neurosurgery, and Psychiatry. 2005; 76:1455–6.CrossRefGoogle ScholarPubMed
Qureshi, A I. HIV infection and stroke: If not protein S deficiency then what explains the relationship? Journal of Neurology, Neurosurgery, and Psychiatry. 2005; 76:1331.CrossRefGoogle Scholar
Vaughn, G, Detels, R. Protease inhibitors and cardiovascular disease: Analysis of the Los Angeles County Adult Spectrum of Disease cohort. AIDS Care. 2007; 19:492–9.CrossRefGoogle ScholarPubMed
Monsuez, J J, Goujon, C, Wyplosz, B, et al. Cerebrovascular diseases in HIV-infected patients. Current HIV Research. 2009; 7:475–80.CrossRefGoogle ScholarPubMed
Corral, I, Quereda, C, Moreno, A, et al. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: Incidence and risk factors. Cerebrovascular Diseases. 2009; 27:559–63.CrossRefGoogle ScholarPubMed
Ortiz, G, Koch, S, Romano, J G, Forteza, A M, Rabinstein, A A. Mechanisms of ischemic stroke in HIV-infected patients. Neurology. 2007; 68:1257–61.CrossRefGoogle ScholarPubMed
Mangili, A, Gerrior, J, Tang, A M, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: A study using carotid intima-media thickness and coronary artery calcium score. Clinical Infectious Diseases. 2006; 43:1482–9.CrossRefGoogle Scholar
Sen, S, Rabinstein, A A, Elkind, M S, Powers, W J. Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovascular Diseases. 2012; 33:209–18.CrossRefGoogle ScholarPubMed
Dobbs, M R, Berger, J R. Stroke in HIV infection and AIDS. Expert Review of Cardiovascular Therapy. 2009; 7:1263–71.CrossRefGoogle ScholarPubMed
Chen, S P, Fuh, J L, Wang, S J. Reversible cerebral vasoconstriction syndrome: Current and future perspectives. Expert Review of Neurotherapeutics. 2011; 11:1265–76.CrossRefGoogle ScholarPubMed
Salvarani, C, Brown, R D Jr., Hunder, G G. Adult primary central nervous system vasculitis. Lancet. 2012; 380:767–77.CrossRefGoogle ScholarPubMed
Calabrese, L H, Duna, G F. Drug-induced vasculitis. Current Opinion in Rheumatology. 1996; 8:34–40.CrossRefGoogle ScholarPubMed
Citron, B P, Halpern, M, McCarron, M, et al. Necrotizing angiitis associated with drug abuse. New England Journal of Medicine. 1970; 283:1003–11.CrossRefGoogle ScholarPubMed
Lim, D, Rademaker, M, Asztely, F, Ratnaweera, M, Coltman, G. Cerebral vasculitis and multi-focal neurological deficits due to allopurinol-induced hypersensitivity syndrome. Australasian Journal of Dermatology. 2013.CrossRefGoogle Scholar
Rothwell, P M, Grant, R. Cerebral vasculitis following allopurinol treatment. Postgraduate Medical Journal. 1996; 72:119–20.CrossRefGoogle ScholarPubMed
Flaherty, M L, Kissela, B, Woo, D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007; 68:116–21.CrossRefGoogle ScholarPubMed
Whitlock, R P, Sun, J C, Fremes, S E, Rubens, F D, Teoh, K H. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:e576S–600S.CrossRefGoogle ScholarPubMed
You, J J, Singer, D E, Howard, P A, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:e531S–575S.CrossRefGoogle ScholarPubMed
Ageno, W, Gallus, A S, Wittkowsky, A, et al. Oral anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141:e44S–88S.CrossRefGoogle ScholarPubMed
Hylek, E M, Skates, S J, Sheehan, M A, Singer, D E. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. New England Journal of Medicine. 1996; 335:540–6.CrossRefGoogle ScholarPubMed
Hart, R G, Boop, B S, Anderson, D C. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995; 26:1471–7.CrossRefGoogle Scholar
Fang, M C, Go, A S, Chang, Y, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. American Journal of Medicine. 2007; 120:700–5.CrossRefGoogle ScholarPubMed
Quinones-Hinojosa, A, Gulati, M, Singh, V, Lawton, M T. Spontaneous intracerebral hemorrhage due to coagulation disorders. Neurosurgical Focus. 2003; 15:E3.CrossRefGoogle ScholarPubMed
Hampton, K K, Preston, F E. ABC of clinical haematology. Bleeding disorders, thrombosis, and anticoagulation. British Medical Journal. 1997; 314:1026–9.CrossRefGoogle ScholarPubMed
Vernooij, M W, Haag, M D, van der Lugt, A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: The Rotterdam scan study. Archives of Neurology. 2009; 66:714–20.CrossRefGoogle ScholarPubMed
Thompson, B B, Bejot, Y, Caso, V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: A systematic review. Neurology. 2010; 75:1333–42.CrossRefGoogle ScholarPubMed
Naidech, A M, Bendok, B R, Garg, R K, et al. Reduced platelet activity is associated with more intraventricular hemorrhage. Neurosurgery. 2009; 65:684–8.CrossRefGoogle ScholarPubMed
He, J, Whelton, P K, Vu, B, Klag, M J. Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trials. Journal of the American Medical Association. 1998; 280:1930–5.Google ScholarPubMed
Foerch, C, Sitzer, M, Steinmetz, H, Neumann-Haefelin, T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke. 2006; 37:2165–7.CrossRefGoogle Scholar
Toyoda, K, Okada, Y, Minematsu, K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005; 65:1000–4.CrossRefGoogle ScholarPubMed
Toyoda, K, Yasaka, M, Nagata, K, et al. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The bleeding with antithrombotic therapy (BAT) retrospective study. Cerebrovascular Diseases. 2009; 27:151–9.CrossRefGoogle ScholarPubMed
Saloheimo, P, Ahonen, M, Juvela, S, et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006; 37:129–33.CrossRefGoogle Scholar
Creutzfeldt, C J, Weinstein, J R, Longstreth, W T Jr., et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. Journal of Stroke & Cerebrovascular Diseases. 2009; 18:221–8.CrossRefGoogle ScholarPubMed
Caso, V, Paciaroni, M, Venti, M, et al. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage. Cerebrovascular Diseases. 2007; 24:215–18.CrossRefGoogle ScholarPubMed
Roquer, J, Rodriguez Campello, A, Gomis, M, et al. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. Journal of Neurology. 2005; 252:412–16.CrossRefGoogle Scholar
Lacut, K, Le Gal, G, Seizeur, R, et al. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundamental & Clinical Pharmacology. 2007; 21:327–33.CrossRefGoogle ScholarPubMed
Hanger, H C, Fletcher, V J, Wilkinson, T J, et al. Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. Journal of Neurology. 2008; 255:347–52.CrossRefGoogle ScholarPubMed
Sansing, L H, Messe, S R, Cucchiara, B L, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009; 72:1397–402.CrossRefGoogle ScholarPubMed
Moussouttas, M, Malhotra, R, Fernandez, L, et al. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocritical Care. 2010; 12:24–9.CrossRefGoogle ScholarPubMed
Stead, L G, Jain, A, Bellolio, M F, et al. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome? Clinical Neurology & Neurosurgery. 2010; 112:275–81.CrossRefGoogle ScholarPubMed
Ishibashi, A, Yokokura, Y, Adachi, H. Is antiplatelet therapy for the prevention of ischemic stroke associated with the prognosis of intracerebral hemorrhage? Kurume Medical Journal. 2008; 55:71–5.CrossRefGoogle ScholarPubMed
Nicolini, A, Ghirarduzzi, A, Iorio, A, et al. Intracranial bleeding: Epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica. 2002; 87:948–56.Google ScholarPubMed
Baldi, G, Altomonte, F, Altomonte, M, et al. Intracranial haemorrhage in patients on antithrombotics: Clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovascular Diseases. 2006; 22:286–93.CrossRefGoogle Scholar
Lovelock, C E, Cordonnier, C, Naka, H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: A systematic review of published and unpublished studies. Stroke. 2010; 41:1222–8.CrossRefGoogle ScholarPubMed
Naidech, A M, Bernstein, R A, Levasseur, K, et al. Platelet activity and outcome after intracerebral hemorrhage. Annals of Neurology. 2009; 65:352–6.CrossRefGoogle ScholarPubMed
Naidech, A M, Jovanovic, B, Liebling, S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009; 40:2398–401.CrossRefGoogle ScholarPubMed
de Gans, K, de Haan, R J, Majoie, C B, et al. PATCH: Platelet Transfusion in Cerebral Haemorrhage: Study protocol for a multicentre, randomised, controlled trial. BMC Neurology. 2010; 10:19.CrossRefGoogle ScholarPubMed
Memon, M A, Blankenship, J C, Wood, G C, Frey, C M, Menapace, F J. Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis of major clinical trials. American Journal of Medicine. 2000; 109:213–17.CrossRefGoogle ScholarPubMed
Qureshi, A I, Suri, M F, Ali, Z, et al. Carotid angioplasty and stent placement: A prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002; 50:466–73.Google ScholarPubMed
Qureshi, A I, Saad, M, Zaidat, O O, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002; 33:1916–19.CrossRefGoogle ScholarPubMed
Adams, H P Jr., Effron, M B, Torner, J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase III trial: Abciximab in emergency treatment of stroke trial (ABESTT-II). Stroke. 2008; 39:87–99.CrossRefGoogle ScholarPubMed
Adams, H P Jr., Leira, E C, Torner, J C, et al. Treating patients with “wake-up” stroke: The experience of the ABESTT-II trial. Stroke. 2008; 39:3277–82.CrossRefGoogle ScholarPubMed
Hirsh, J, Guyatt, G, Albers, G W, Harrington, R, Schunemann, H J, American College of Chest Physicians. Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133:110S–112S.CrossRefGoogle ScholarPubMed
The National Institute of Neurological Disorders and Stroke RT-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine. 1995; 333:1581–7.Google Scholar
Strbian, D, Sairanen, T, Meretoja, A, et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology. 2011; 77:341–8.CrossRefGoogle ScholarPubMed
Herrmann, N, Lanctot, K L. Do atypical antipsychotics cause stroke? CNS Drugs. 2005; 19:91–103.CrossRefGoogle ScholarPubMed
Sacchetti, E, Turrina, C, Valsecchi, P. Cerebrovascular accidents in elderly people treated with antipsychotic drugs: A systematic review. Drug Safety. 2010; 33:273–88.CrossRefGoogle ScholarPubMed
Christensen, S, Mehnert, F, Chapurlat, R D, Baron, J A, Sorensen, H T. Oral bisphosphonates and risk of ischemic stroke: A case-control study. Osteoporosis International. 2011; 22:1773–9.CrossRefGoogle ScholarPubMed
Wilkinson, G S, Baillargeon, J, Kuo, Y F, Freeman, J L, Goodwin, J S. Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer. Journal of Clinical Oncology. 2010; 28:4898–905.CrossRefGoogle ScholarPubMed
Gallagher, A M, Smeeth, L, Seabroke, S, Leufkens, H G, van Staa, T P. Risk of death and cardiovascular outcomes with thiazolidinediones: A study with the general practice research database and secondary care data. PloS One. 2011; 6:e28157.CrossRefGoogle ScholarPubMed
Panicker, G K, Karnad, D R, Salvi, V, Kothari, S. Cardiovascular risk of oral antidiabetic drugs: Current evidence and regulatory requirements for new drugs. J Assoc Physicians India. 2012; 60:56–61.Google ScholarPubMed
Morgenstern, L B, Hemphill, J C 3rd, Anderson, C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010; 41:2108–29.CrossRefGoogle ScholarPubMed
Jauch, E C, Saver, J L, Adams, H P Jr. et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44:870–947.CrossRefGoogle ScholarPubMed
Ducros, A, Bousser, M G. Reversible cerebral vasoconstriction syndrome. Practical Neurology. 2009; 9:256–67.CrossRefGoogle ScholarPubMed
Mittal, M K, Rabinstein, A A. Anticoagulation-related intracranial hemorrhages. Current Atherosclerosis Reports. 2012; 14:351–9.CrossRefGoogle ScholarPubMed
Hirsh, J, Anand, S S, Halperin, J L, Fuster, V. Mechanism of action and pharmacology of unfractionated heparin. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001; 21:1094–6.CrossRefGoogle ScholarPubMed
Choay, J, Petitou, M, Lormeau, JC, et al. Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochemical and Biophysical Research Communications. 1983; 116:492–9.CrossRefGoogle ScholarPubMed
Crowther, M A, Warkentin, T E. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: Focus on new anticoagulant agents. Blood. 2008; 111:4871–9.CrossRefGoogle ScholarPubMed
Watanabe, M, Siddiqui, F M, Qureshi, A I. Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment. Neurocritical Care. 2012; 16:203–9.CrossRefGoogle ScholarPubMed
Baz, R, Mekhail, T. Disorders of platelet function and number. 2010.CrossRefGoogle Scholar
Konkle, B A. Acquired disorders of platelet function. ASH Education Program Book. 2011; 391–6.CrossRefGoogle Scholar
Kenney, B, Stack, G. Drug-induced thrombocytopenia. Archives of Pathology and Laboratory Medicine. 2009; 133:309–14.CrossRefGoogle ScholarPubMed
Steiner, T, Poli, S, Griebe, M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage (INCH): a randomized trial. Lancet. 2016; 15:566–73.Google Scholar
Pollack, C V, Reilly, P A, Eikelboom, J, et al. Idarucizamab for dibigatran reversal. New England Journal of Medicine. 2015; 373:511–20.CrossRefGoogle Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×